Nouvelles Eulerpool Syndax Pharmaceuticals

Eulerpool-AFX Syndax Pharmaceuticals

Syndax Pharmaceuticals Actualités des actions

Syndax Pharmaceuticals est surveillé par de nombreux journalistes et investisseurs du monde entier. Nous regroupons ici les dernières actualités Syndax Pharmaceuticals.

• 1 octobre ·

  TipRanks
  Analysts Offer Insights on Healthcare Companies: Waters (WAT), Neurocrine (NBIX) and Syndax Pharmaceuticals (SNDX)
• 27 septembre ·

  Thefly.com
  Syndax placed on 'Positive Catalyst Watch' at JPMorgan
• 23 septembre ·

  SeekingAlpha
  Syndax Pharmaceuticals: One Down And One To Go
• 20 septembre ·

  SeekingAlpha
  Syndax Pharmaceuticals: Navigating Through A Pivotal Year
• 18 septembre ·

  Yahoo
  Incyte and Syndax Announce New England Journal of Medicine Publication of Data from Pivotal AGAVE-201 Trial of Niktimvo™ (axatilimab-csfr) in Chronic Graft-Versus-Host Disease
• 18 septembre ·

  PR Newswire
  Incyte and Syndax Announce New England Journal of Medicine Publication of Data from Pivotal AGAVE-201 Trial of Niktimvo? (axatilimab-csfr) in Chronic Graft-Versus-Host Disease
• 18 septembre ·

  Thefly.com
  Syndax and Incyte announce publication of positive Niktimvo results in GVHD
• 13 septembre ·

  Yahoo
  We Think Syndax Pharmaceuticals (NASDAQ:SNDX) Needs To Drive Business Growth Carefully
• 6 septembre ·

  Yahoo
  Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
• 5 septembre ·

  Yahoo
  Syndax Pharmaceuticals, Inc. (SNDX): This Small-Cap Healthcare Stock Is A Good Buy Right Now